At Texas TMS Center, our goal is to collaborate with you in the care of your patients with depression. We aim to be an extension of the treatment you offer to your patients who have not responded to traditional treatments.

We invite your input and participation in the treatment process to create a seamless continuum of care. We will communicate with you regularly on your patient’s progress towards our mutual treatment goals.

We welcome your inquiries on TMS and will gladly give you a personal demonstration of the NeuroStarTMS System. Please call to schedule your visit to our office.

 

Healthcare Professionals - Relevant Forms and Downloads

NeuroStar Care Connection Enrollment Form

Antidepressant efficacy of Transcranial Magnetic Stimulation: a meta-analysis

Based on the 2010 APA (Americal Psychiatric Association) the guidelines changed to include NeuroStar TMS Therapy as a second-line treatment modality

Click here to see the APA's 2010 Best Practices Treatment Guide for Depression (this guide is 2 pages, be sure to scroll down to see 2nd page)

 

In May of 2010, The National Institutes of Health (NIH) published the results of their study on TMS therapy titled - Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder -A Sham-Controlled Randomized Trial. The objective of this study was to test whether daily left prefrontal rTMS safely and effectively treats major depressive disorder(MDD). Approximately 860 outpatients were screened, yielding 199 antidepressant drug–free patients with unipolar nonpsychotic major depressive disorder. In this National Institutes of Health–sponsored, industry-independent trial, high-intensity rTMS for at least 3 weeks was significantly more likely than sham rTMS to induce remission in antidepressant medication–free patients with moderately treatment-resistant unipolar MDD. The results of this study suggest that prefrontal rTMS is a monotherapy with few adverse effects and significant antidepressant effects for unipolar depressed patients who do not respond to medications or who cannot tolerate them.